Montinex Fast Chewable Tablet 10 mg

Montinex Fast is a widely used respiratory medication containing Montelukast Sodium 10 mg as its active ingredient. Manufactured by Beacon Pharmaceuticals PLC, this Chewable Tablet effectively manages asthma, exercise-induced bronchoconstriction, and allergic rhinitis. Priced at ৳18.00 per unit (৳180.00 per strip), it offers cost-effective long-term therapy for chronic respiratory conditions.

The drug works by blocking leukotriene receptors, reducing inflammation and airway constriction. Adults and adolescents take 10 mg daily, while pediatric doses vary by age. Storage requires cool, dry conditions below 30°C. Key LSI keywords: Montinex Fast uses, Montelukast Sodium brand, asthma medication Bangladesh.

Indications include prevention of asthma attacks, seasonal allergies, and exercise-induced breathing difficulties. Its unique mechanism minimizes reliance on inhaled corticosteroids. Patients report improved nighttime symptoms when taken regularly. Always consult doctors before combining with NSAIDs or anticoagulants like warfarin.

Common side effects like headache (12% users) and abdominal pain are generally mild. Rare psychiatric reactions (<1%) necessitate immediate medical attention. Pregnant women should use it only if benefits outweigh potential risks. Overdose management focuses on symptom relief and gastrointestinal decontamination.

Adults (15+ years): 10 mg once daily. Children (6-14 years): 5 mg, 6 months-5 years: 4 mg. For asthma/allergic rhinitis: Take at night. For exercise-induced bronchoconstriction: Take 2 hours before activity. May be taken with/without food. Long-term use requires medical supervision.

Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.

Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.

Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.

Pregnancy Category B: Use only if benefit justifies risk. Excreted in breast milk—caution during lactation.

Not for acute asthma attacks. Monitor neuropsychiatric symptoms (agitation, suicidal ideation). Regular liver function tests advised.

No dose adjustment for elderly. Limited data for hepatic/renal impairment. Not recommended below 6 months.

There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Montinex Fast and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.